发明名称 |
ANTIBODY FORMULATIONS AND METHODS |
摘要 |
Antibody formulations and methods useful for prophylaxis or treatment of amyloidosis, including AA amyloidosis and AL amyloidosis. |
申请公布号 |
US2014302021(A1) |
申请公布日期 |
2014.10.09 |
申请号 |
US201214354124 |
申请日期 |
2012.10.25 |
申请人 |
ONCLAVE THERAPEUTICS LIMITED |
发明人 |
Garidel Patrick;Henderson Isaac Craig;Klein Pamela |
分类号 |
C07K16/18;A61K31/195;A61K31/69;A61K39/395 |
主分类号 |
C07K16/18 |
代理机构 |
|
代理人 |
|
主权项 |
1. A pharmaceutical formulation comprising:
(a) a chimeric or humanized version of antibody 2A4 (ATCC Accession Number PTA-9662) or of antibody 7D8 (ATCC Accession Number PTA-9468), or fragment thereof, that specifically competes for binding to antigen with 2A4 or 7D8, wherein the antibody is present at a concentration within the range from about 1 mg/mL to about 100 mg/mL; (b) histidine buffer present at a concentration within the range from about 20 mM to about 30 mM; (c) trehalose present at a concentration within the range from about 210 mM to about 250 mM; and (d) polysorbate 20 present at a concentration within the range from about 0.005% to about 0.05% by weight; wherein the formulation is characterized by a pH within the range from about 6 to about 7. |
地址 |
Dublin 2 IE |